397 related articles for article (PubMed ID: 22151936)
21. The treatment of melasma: a review of clinical trials.
Gupta AK; Gover MD; Nouri K; Taylor S
J Am Acad Dermatol; 2006 Dec; 55(6):1048-65. PubMed ID: 17097400
[TBL] [Abstract][Full Text] [Related]
22. Preventing melasma recurrence: prescribing a maintenance regimen with an effective triple combination cream based on long-standing clinical severity.
Arellano I; Cestari T; Ocampo-Candiani J; Azulay-Abulafia L; Bezerra Trindade Neto P; Hexsel D; Machado-Pinto J; Muñoz H; Rivitti-Machado MC; Sittart JA; Trindade de Almeida AR; Rego V; Paliargues F; Marques-Hassun K
J Eur Acad Dermatol Venereol; 2012 May; 26(5):611-8. PubMed ID: 21623930
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of serial glycolic acid peels and a topical regimen in the treatment of recalcitrant melasma.
Erbil H; Sezer E; Taştan B; Arca E; Kurumlu Z
J Dermatol; 2007 Jan; 34(1):25-30. PubMed ID: 17204097
[TBL] [Abstract][Full Text] [Related]
24. Comparison of efficacy of products containing azelaic acid in melasma treatment.
Mazurek K; Pierzchała E
J Cosmet Dermatol; 2016 Sep; 15(3):269-82. PubMed ID: 27028014
[TBL] [Abstract][Full Text] [Related]
25. Combination of Oral Tranexamic Acid with Topical 3% Tranexamic Acid versus Oral Tranexamic Acid with Topical 20% Azelaic Acid in the Treatment of Melasma.
Malik F; Hanif MM; Mustafa G
J Coll Physicians Surg Pak; 2019 Jun; 29(6):502-504. PubMed ID: 31133144
[TBL] [Abstract][Full Text] [Related]
26. Comparative Evaluation of Efficacy and Tolerability of Glycolic Acid, Salicylic Mandelic Acid, and Phytic Acid Combination Peels in Melasma.
Sarkar R; Garg V; Bansal S; Sethi S; Gupta C
Dermatol Surg; 2016 Mar; 42(3):384-91. PubMed ID: 26859648
[TBL] [Abstract][Full Text] [Related]
27. Melasma. Etiologic and therapeutic considerations.
Grimes PE
Arch Dermatol; 1995 Dec; 131(12):1453-7. PubMed ID: 7492140
[TBL] [Abstract][Full Text] [Related]
28. Melanin hyperpigmentation of skin: melasma, topical treatment with azelaic acid, and other therapies.
Breathnach AS
Cutis; 1996 Jan; 57(1 Suppl):36-45. PubMed ID: 8654129
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of the efficacy of cysteamine cream compared to hydroquinone in the treatment of melasma: A randomised, double-blinded trial.
Nguyen J; Remyn L; Chung IY; Honigman A; Gourani-Tehrani S; Wutami I; Wong C; Paul E; Rodrigues M
Australas J Dermatol; 2021 Feb; 62(1):e41-e46. PubMed ID: 32981068
[TBL] [Abstract][Full Text] [Related]
30. A double-blind randomized trial of 5% ascorbic acid vs. 4% hydroquinone in melasma.
Espinal-Perez LE; Moncada B; Castanedo-Cazares JP
Int J Dermatol; 2004 Aug; 43(8):604-7. PubMed ID: 15304189
[TBL] [Abstract][Full Text] [Related]
31. Melasma: treatment evaluation.
Salem A; Gamil H; Ramadan A; Harras M; Amer A
J Cosmet Laser Ther; 2009 Sep; 11(3):146-50. PubMed ID: 19340686
[TBL] [Abstract][Full Text] [Related]
32. A comparison of triple combination cream and hydroquinone 4% cream for the treatment of moderate to severe facial melasma.
Ferreira Cestari T; Hassun K; Sittart A; de Lourdes Viegas M
J Cosmet Dermatol; 2007 Mar; 6(1):36-9. PubMed ID: 17348994
[TBL] [Abstract][Full Text] [Related]
33. Successful treatment of hydroquinone-resistant melasma using topical methimazole.
Malek J; Chedraoui A; Nikolic D; Barouti N; Ghosn S; Abbas O
Dermatol Ther; 2013; 26(1):69-72. PubMed ID: 23384022
[TBL] [Abstract][Full Text] [Related]
34. Randomised, controlled, double-blind study of combination therapy of oral tranexamic acid and topical hydroquinone in the treatment of melasma.
Shihab N; Prihartono J; Tovar-Garza A; Agustin T; Legiawati L; Pandya AG
Australas J Dermatol; 2020 Aug; 61(3):237-242. PubMed ID: 32109318
[TBL] [Abstract][Full Text] [Related]
35. Azelaic acid and glycolic acid combination therapy for facial hyperpigmentation in darker-skinned patients: a clinical comparison with hydroquinone.
Kakita LS; Lowe NJ
Clin Ther; 1998; 20(5):960-70. PubMed ID: 9829447
[TBL] [Abstract][Full Text] [Related]
36. 755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lai D; Cheng S; Zhou S; Hao J; Chen H; Jia K; Liu H; Cui Y
Lasers Med Sci; 2024 Apr; 39(1):113. PubMed ID: 38656631
[TBL] [Abstract][Full Text] [Related]
37. Efficacy of Trichloro-Acetic Acid Peel Alone Versus Combined Topical Magnesium Ascorbyl Phosphate for Epidermal Melasma.
Murtaza F; Bangash AR; Khushdil A; Noor SM
J Coll Physicians Surg Pak; 2016 Jul; 26(7):557-61. PubMed ID: 27504543
[TBL] [Abstract][Full Text] [Related]
38. Community-based trial of a triple-combination agent for the treatment of facial melasma.
Grimes P; Kelly AP; Torok H; Willis I
Cutis; 2006 Mar; 77(3):177-84. PubMed ID: 16610738
[TBL] [Abstract][Full Text] [Related]
39. A novel triple combination in treatment of melasma: Significant outcome with far less actives.
Pekmezci E
J Cosmet Dermatol; 2019 Dec; 18(6):1700-1704. PubMed ID: 30920111
[TBL] [Abstract][Full Text] [Related]
40. Open-label evaluation of a novel skin brightening system containing 0.01% decapeptide-12 in combination with 20% buffered glycolic acid for the treatment of mild to moderate facial melasma.
Ramírez SP; Carvajal AC; Salazar JC; Arroyave G; Flórez AM; Echeverry HF
J Drugs Dermatol; 2013 Jun; 12(6):e106-10. PubMed ID: 23839199
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
